KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 108 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 4.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,026,427 | +16.2% | 521,891 | +8.6% | 0.00% | 0.0% |
| Q2 2023 | $4,323,825 | +17.7% | 480,425 | +2.8% | 0.00% | – |
| Q1 2023 | $3,674,424 | +136495.7% | 467,484 | +17.4% | 0.00% | – |
| Q4 2022 | $2,690 | -100.0% | 398,075 | -4.0% | 0.00% | -100.0% |
| Q3 2022 | $6,019,000 | +54.1% | 414,859 | +4.5% | 0.00% | 0.0% |
| Q2 2022 | $3,906,000 | -35.2% | 397,015 | -2.9% | 0.00% | 0.0% |
| Q1 2022 | $6,029,000 | +20.6% | 409,026 | +8.2% | 0.00% | 0.0% |
| Q4 2021 | $5,000,000 | -22.2% | 377,970 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $6,424,000 | -20.5% | 368,140 | +9.2% | 0.00% | 0.0% |
| Q2 2021 | $8,081,000 | -3.9% | 337,277 | +3.1% | 0.00% | 0.0% |
| Q1 2021 | $8,407,000 | +96.4% | 327,267 | +45.2% | 0.00% | 0.0% |
| Q4 2020 | $4,280,000 | +63.5% | 225,419 | +8.4% | 0.00% | 0.0% |
| Q3 2020 | $2,617,000 | +9.1% | 207,877 | +4.8% | 0.00% | 0.0% |
| Q2 2020 | $2,399,000 | +63.6% | 198,285 | +3.5% | 0.00% | – |
| Q1 2020 | $1,466,000 | -74.9% | 191,669 | -41.5% | 0.00% | -100.0% |
| Q4 2019 | $5,838,000 | +231.7% | 327,812 | +116.0% | 0.00% | – |
| Q3 2019 | $1,760,000 | -44.0% | 151,781 | +7.0% | 0.00% | -100.0% |
| Q2 2019 | $3,142,000 | +32.1% | 141,869 | +70.7% | 0.00% | 0.0% |
| Q1 2019 | $2,378,000 | -28.2% | 83,095 | -50.5% | 0.00% | 0.0% |
| Q4 2018 | $3,312,000 | +133.4% | 167,762 | +161.1% | 0.00% | – |
| Q3 2018 | $1,419,000 | +744.6% | 64,245 | +209.4% | 0.00% | – |
| Q2 2018 | $168,000 | -14.3% | 20,762 | 0.0% | 0.00% | – |
| Q1 2018 | $196,000 | -3.0% | 20,762 | 0.0% | 0.00% | – |
| Q4 2017 | $202,000 | – | 20,762 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $25,679,000 | 12.37% |
| Vivo Capital, LLC | 1,618,296 | $30,731,000 | 1.37% |
| Opaleye Management Inc. | 470,203 | $8,929,000 | 1.17% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $7,383,000 | 0.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 177,433 | $3,369,000 | 0.92% |
| Ikarian Capital, LLC | 1,063,961 | $20,204,000 | 0.89% |
| Ghost Tree Capital, LLC | 200,000 | $3,798,000 | 0.85% |
| Logos Global Management LP | 490,000 | $9,305,000 | 0.80% |
| Eventide Asset Management | 1,680,000 | $31,903,000 | 0.49% |
| Affinity Asset Advisors, LLC | 45,000 | $855,000 | 0.45% |